Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Understand when rebalancing triggers capital gains taxes and how to plan for them. This intro highlights key rules and proactive strategies.
23,600 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
XRP surged to $1.60 on the regulatory milestone, then faded as macro headwinds and rising yields pressured all risk a...
Navan stock soared today as the company posted solid growth and highlighted AI-driven efficiencies in its platform. T...
Bank of America upgrades FedEx to its US 1 List, signaling confidence in the company’s DRIVE plan and a stabilizing l...
This in-depth look at Ideal Power's Q1 2026 earnings breaks down the numbers, the growth drivers, and what it means f...
Metropolis has surged to a $5 billion valuation after a 2025 funding round, transforming parking networks into a broa...
Investors chased space-focused stocks higher on SpaceX IPO speculation, lifting Spacemobile 20%, Planet Labs 15%, and...
Bitcoin dips below $72,000 as several altcoins surge with double-digit gains, creating a mixed market mood and renewe...
A high-yield financial stock can be tempting, but the window to lock in that income is narrow. Learn how to evaluate ...
The NEOS QQQI ETF offers a high monthly yield, but hidden costs could erode capital in calmer markets. This report ex...
A top Wells Fargo strategist urges retail investors to look for buying opportunities on market dips sparked by Fed ti...
A tech sector retreat has pulled many chip names lower, but weakness can create entry points. Here are three beaten-d...